Company Mydecine Innovations Group Inc.
Equities
MYCOF
CA62849F2008
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0059 USD | -45.87% | +9.26% | -60.40% |
Feb. 23 | Mydecine Innovations Closes Partial Debt Settlement | MT |
Feb. 02 | Mydecine Innovations Group Inc Announces Resignation of Neil Stevenson-Moore as Director | CI |
Business Summary
Number of employees: 3
Managers
Managers | Title | Age | Since |
---|---|---|---|
Robert Roscow
FOU | Founder | - | 13-09-26 |
Damon Michaels
FOU | Founder | - | 13-09-26 |
David Bartch
CEO | Chief Executive Officer | - | 18-06-21 |
John Ross
DFI | Director of Finance/CFO | 65 | 22-09-15 |
Sanford Stein
CMP | Compliance Officer | - | 19-12-31 |
Rakesh Jetly
CTO | Chief Tech/Sci/R&D Officer | 57 | 20-11-16 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Bartch
CEO | Chief Executive Officer | - | 18-06-21 |
Damon Michaels
FOU | Founder | - | 13-09-26 |
Robert Roscow
FOU | Founder | - | 13-09-26 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 61,755,385 | 61,161,194 ( 99.04 %) | 0 | 99.04 % |
Company contact information
Mydecine Innovations Group, Inc.
789 West Pender Street Suite 810
V6C 1H2, Vancouver
+720-277-9879
http://mydecine.comSector
Sales per region
1st Jan change | Capi. | |
---|---|---|
-60.40% | 673K | |
+3.59% | 43.43B | |
+47.81% | 41.69B | |
+8.86% | 41.31B | |
-10.92% | 27.14B | |
+8.46% | 25.28B | |
-24.68% | 18.47B | |
+28.83% | 12.59B | |
+0.66% | 12.33B | |
+9.14% | 11.03B |
- Stock Market
- Equities
- MYCOF Stock
- Company Mydecine Innovations Group Inc.